Form 4 for VRDN Viridian Therapeutics, Inc.\DE
Accepted 2022-04-05 00:00:00 ET · period of report 2022-04-01 · accession 0000899243-22-013858 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-04-05 | 2022-04-01+ | VRDN | Violin Jonathan | CEO, Dir | S - Sale | $18.92 | -30.0K | 540.9K | -5% | -$567.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-01 | S | D | 26,400 | $18.92 | 544,505 | D | — | — | (F1) This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $18.34 to $19.43. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2022-04-04 | S | D | 3,600 | $18.93 | 540,905 | D | — | — | (F2) This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $18.64 to $19.16. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |